The mission of Boehringer Ingelheim Vetmedica, Inc. is to benefit the health and well-being of mankind by contributing to an adequate supply of safe, nutritious food and by promoting the emotional and physical benefits arising from the human-animal bond.
Boehringer Ingelheim Vetmedica, Inc., headquartered in St. Joseph, Missouri, is a subsidiary of Boehringer Ingelheim Corporation, based in Ridgefield, Connecticut, and is a member of the Boehringer Ingelheim group of companies.
Boehringer Ingelheim Vetmedica, Inc., headquartered in St. Joseph, Missouri, is a subsidiary of Boehringer Ingelheim Corporation, based in Ridgefield, Connecticut, and is a member of the Boehringer Ingelheim group of companies.
News & Announcements
- 23 November 2009 Boehringer Ingelheim Introduces New Vetera West Nile Virus Vaccines
- 12 November 2009 PROZINC™ (protamine zinc recombinant human insulin) Receives FDA Approval
- 26 October 2009 Boehringer Ingelheim Animal Health Closes Deal to Acquire a Significant Portion of the Fort Dodge Animal Health Business from Pfizer
- 1 October 2009 Mobile Dog Heart Health Tour Stopping in Central Park to Provide Free Heart Examinations
- 21 September 2009 BIVI Aquires Many of Fort Dodge's Products
- 17 August 2009 Midwest Mobile Dog Heart Health Tour to Provide Free Heart Examinations
- 9 August 2009 Boehringer Ingelheim Announces 2009 PRRS Research Award Recipients
- 5 August 2009 Swine Industry Call for PRRS Research Proposals